Search Browse Earnings

REGENTIS BIOMATERIALS LTD.

NYSE:RGNT

Orthopedic, Prosthetic & Surgical Appliances & Supplies·OR AKIVA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

REGENTIS BIOMATERIALS LTD. — SlamSEC

Revenue

—

Adj. EBITDA

—

Net Income

-$4.1M

FY 2025

EPS (Diluted)

-$24.09

FY 2025

Stock Price

$3.36

+0.3%

2026-03-06

52W Range

$3.10 – $8.35

P/E Ratio

-0.1x

Market Cap

$17.4M

Cash

$7.4M

FY 2025

Total Debt

$325,000

FY 2025

Net Cash

$7.1M

FY 2025

Enterprise Value

$10.3M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—